Poziotinib Active Not Recruiting Phase 1 Trials for Cancer, Breast Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03429101A Study of Poziotinib in Combination With T-DM1 in HER2-Positive Breast Cancer